Synthesis of the 16α,17α,21-trimethyl corticosteroid rimexolone from prednisolone

Journal of Organic Chemistry

Volumn 64, Issue 3, 1999, Pages 1042-1044

  Conrow, Raymond E ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA,17ALPHA,21 TRIMETHYLCORTICOSTEROID; DEXAMETHASONE; IODIDE; PREDNISOLONE; PREDNISOLONE TRIACETATE; RIMEXOLONE; TOLUENESULFONIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DEHYDRATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOCULAR PRESSURE ABNORMALITY; METHYLATION; STEROIDOGENESIS; VALIDATION PROCESS;

EID: 0033524880     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo981848x     Document Type: Article

References (43)

1. (a) Boltralik, J. J. U.S. Patent 4,686,214.
2. (b) Cheng, X.-M. Annu. Rep. Med. Chem. 1996, 31, 348.
3. (c) Yang, J.; Foster, C. S. Drugs Today 1997, 33, 123.
4. (d) Drugs Future 1997, 22, 1177.
5. Cairns, J.; Logan, R. T.; McGarry, G.; Roy, R. G.; Stevenson, D. F. M.; Woods, G. F. J. Chem. Soc., Perkin Trans. 1 1981, 2306.
6. (a) Livingston, D. A. In Advances in Medicinal Chemistry; Maryanoff, B. E., Maryanoff, C. A., Eds.; JAI Press: Greenwich, CT, 1992; Vol. 1, pp 137-174.
7. (b) Livingston, D. A.; Petre, J. E.; Bergh, C. L. J. Am. Chem. Soc. 1990, 112, 6449.
8. (c) Reid, J. G.; Debiak-Krook, T. Tetrahedron Lett. 1990, 31, 3669.
9. (d) Kataoka, H.; Watanabe, K.; Miyazaki, K.-i.; Tahara, S.-i.; Ogu, K.-i.; Matsuoka, R.; Goto, K. Chem. Lett. 1990, 1705.
10. (e) Stoelwinder, J.; van Leusen, A. M. J. Org. Chem. 1993, 58, 3687.
11. (a) Schweder, B.; Uhlig, E.; Döring, M.; Kosemund, D. J. Prakt. Chem. 1993, 335, 439.
12. (b) Kurosu, M.; Kishi, Y. Tetrahedron Lett. 1998, 39, 4793.
13. (a) Kominek, L. A.; Wolf, H. J.; Steiert, P. S. U.S. Patent 5,225,335.
14. (b) Pearlman, B. A. European Patent 464,153 B1.
15. (a) Pinson, E. R., Jr.; Agnello, E. J.; Laubach, G. D. U.S. Patent 3,033,873.
16. (b) Vitali, R.; Gardi, R.; Ercoli, A. Gazz. Chim. Ital. 1966, 96, 1115.
17. 1 and 11β-OH.
18. (a) Kövendi, A.; Bodor, A.; Deésy, A.; Breazu, D. Rev. Chim. (Bucharest) 1976, 27, 467; Chem. Abstr. 1977, 86, 29990.
19. (a) Kövendi, A.; Bodor, A.; Deésy, A.; Breazu, D. Rev. Chim. (Bucharest) 1976, 27, 467; Chem. Abstr. 1977, 86, 29990.
20. (b) Taub, D.; Hoffsommer, R. D.; Wendler, N. L. J. Org. Chem. 1964, 29, 3486.
21. (c) Slates, H. L.; Wendler, N. L. U.S. Patent 3,082,219.
22. Wiechert, R.; Kieslich, K.; Koch, H. U.S. Patent 4,012,510.
23. (a) Salce, L.; Hazen, G. G.; Schoenewaldt, E. F. J. Org. Chem. 1970, 35, 1681.
24. (b) Uszycka-Horawa, T.; Kroszczynski, W. Boll. Chim. Farm. 1990, 129, 230.
25. Hofmeister, H.; Hoyer, G.-A.; Cleve, G.; Laurent, H.; Wiechert, R. Chem. Ber. 1976, 109, 185.
26. 13C NMR spectrum of 13 (δ 120 (CH), 168, 171) is consistent with the 2(5H)-furanone (butenolide) structure, not the 3(2H)-furanone: Guntrum, E.; Kuhn, W.; Spönlein, W.; Jäger, V. Synthesis 1986, 921. Sampson, P.; Roussis, V.; Drtina, G. J.; Koerwitz, F. L.; Wiemer, D. F. J. Org. Chem. 1986, 51, 2525. For the synthesis of steroidal spirobutenolides of opposite C-17 configuration, see: Kamata, S.; Haga, N.; Mitsugi, T.; Kondo, E.; Nagata, W.; Nakamura, M.; Miyata, K.; Odaguchi, K.; Shimizu, T.; Kawabata, T.; Suzuki, T.; Ishibashi, M.; Yamada, F. J. Med. Chem. 1985, 28, 428. For steroidal 3(2H)- furanones, see: Gupta, P. K.; Jones, J. G. Ll.; Caspi, E. J. Org. Chem. 1975, 40, 1420.
27. 13C NMR spectrum of 13 (δ 120 (CH), 168, 171) is consistent with the 2(5H)-furanone (butenolide) structure, not the 3(2H)-furanone: Guntrum, E.; Kuhn, W.; Spönlein, W.; Jäger, V. Synthesis 1986, 921. Sampson, P.; Roussis, V.; Drtina, G. J.; Koerwitz, F. L.; Wiemer, D. F. J. Org. Chem. 1986, 51, 2525. For the synthesis of steroidal spirobutenolides of opposite C-17 configuration, see: Kamata, S.; Haga, N.; Mitsugi, T.; Kondo, E.; Nagata, W.; Nakamura, M.; Miyata, K.; Odaguchi, K.; Shimizu, T.; Kawabata, T.; Suzuki, T.; Ishibashi, M.; Yamada, F. J. Med. Chem. 1985, 28, 428. For steroidal 3(2H)- furanones, see: Gupta, P. K.; Jones, J. G. Ll.; Caspi, E. J. Org. Chem. 1975, 40, 1420.
28. 13C NMR spectrum of 13 (δ 120 (CH), 168, 171) is consistent with the 2(5H)-furanone (butenolide) structure, not the 3(2H)-furanone: Guntrum, E.; Kuhn, W.; Spönlein, W.; Jäger, V. Synthesis 1986, 921. Sampson, P.; Roussis, V.; Drtina, G. J.; Koerwitz, F. L.; Wiemer, D. F. J. Org. Chem. 1986, 51, 2525. For the synthesis of steroidal spirobutenolides of opposite C-17 configuration, see: Kamata, S.; Haga, N.; Mitsugi, T.; Kondo, E.; Nagata, W.; Nakamura, M.; Miyata, K.; Odaguchi, K.; Shimizu, T.; Kawabata, T.; Suzuki, T.; Ishibashi, M.; Yamada, F. J. Med. Chem. 1985, 28, 428. For steroidal 3(2H)- furanones, see: Gupta, P. K.; Jones, J. G. Ll.; Caspi, E. J. Org. Chem. 1975, 40, 1420.
29. 13C NMR spectrum of 13 (δ 120 (CH), 168, 171) is consistent with the 2(5H)-furanone (butenolide) structure, not the 3(2H)-furanone: Guntrum, E.; Kuhn, W.; Spönlein, W.; Jäger, V. Synthesis 1986, 921. Sampson, P.; Roussis, V.; Drtina, G. J.; Koerwitz, F. L.; Wiemer, D. F. J. Org. Chem. 1986, 51, 2525. For the synthesis of steroidal spirobutenolides of opposite C-17 configuration, see: Kamata, S.; Haga, N.; Mitsugi, T.; Kondo, E.; Nagata, W.; Nakamura, M.; Miyata, K.; Odaguchi, K.; Shimizu, T.; Kawabata, T.; Suzuki, T.; Ishibashi, M.; Yamada, F. J. Med. Chem. 1985, 28, 428. For steroidal 3(2H)-furanones, see: Gupta, P. K.; Jones, J. G. Ll.; Caspi, E. J. Org. Chem. 1975, 40, 1420.
30. Hofmeister, H.; Laurent, H.; Wiechert, R. Chem. Ber. 1973, 106, 2263.
31. Two examples of A → B type alkylation in the presence of the A-ring dienone have been recorded: 24 → 25 in ref 2 (30% yield); Example 19 in U.S. Patent 3,862,194 (yield unspecified).
32. (a) Gall, M.; House, H. O. Org. Synth., Coll. Vol. VI, 121.
33. (b) d'Angelo, J. Tetrahedron 1976, 32, 2979.
34. (a) Barton, D. H. R.; Hesse, R. H.; Wilshire, C.; Pechet, M. M. J. Chem. Soc., Perkin Trans. 1 1977, 1075.
35. (b) Barton, D. H. R.; Hesse, R. H.; Tarzia, G.; Pechet, M. M. Chem. Commun. 1969, 1497.
36. (a) Van Rheenen, V. H.; Huber, J. E. U.S. Patent 4,990,612.
37. (b) Horiguchi, Y.; Nakamura, E.; Kuwajima, I. J. Am. Chem. Soc. 1989, 111, 6257.
38. (c) Horiguchi, Y.; Nakamura, E.; Kuwajima, I. Org. Synth. 1995, 73, 123.
39. (d) Buendia, J.; Roussel, P.; Vivat, M. European Patent 574,318 A1.
40. (e) Roussel, P.; Vivat, M. European Patent 608,178 A1.
41. Chapdelaine, M. J.; Hulce, M. Org. React. NY 1990, 38, 225.
42. Kuwajima, I.; Nakamura, E.; Shimizu, M. J. Am. Chem. Soc. 1982, 104, 1025.
43. Lipshutz, B. H.; Sengupta, S. Org. React. NY 1992, 41, 135; cf. p 219.